SYNTHESIS AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF DEQUALINIUM ANALOGS AS K- INVESTIGATION INTO THE ROLE OF THE SUBSTITUENT AT POSITION-4 OF THE QUINOLINE RING( CHANNEL BLOCKERS )

Citation
D. Galanakis et al., SYNTHESIS AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF DEQUALINIUM ANALOGS AS K- INVESTIGATION INTO THE ROLE OF THE SUBSTITUENT AT POSITION-4 OF THE QUINOLINE RING( CHANNEL BLOCKERS ), Journal of medicinal chemistry, 38(18), 1995, pp. 3536-3546
Citations number
80
Categorie Soggetti
Chemistry Medicinal
ISSN journal
00222623
Volume
38
Issue
18
Year of publication
1995
Pages
3536 - 3546
Database
ISI
SICI code
0022-2623(1995)38:18<3536:SAQSOD>2.0.ZU;2-D
Abstract
Dequalinium (4) is a potent and selective blocker of small conductance Ca2+-activated K+ channels, an important but relatively little studie d class. The 4-NH2 group of dequalinium has been shown to contribute s ignificantly to blocking potency. In this study, we have investigated further the role of the 4-NH2 group. Replacement of this group by othe r substituents (R(4)) and quantitative structure-activity relationship (QSAR) analysis on the resultant analogues have yielded a correlation between blocking potency and sigma(R) for R(4) for seven of the compo unds. The application of calculated electronic indices enabled the ext ension of the QSAR to compounds for which the appropriate sigma(R) val ues are not available, allowing all 13 analogues of this series to be included in the correlations. Analysis using electronic indices obtain ed from AM1 MO calculations on model compounds revealed that the block ing potency correlates with the partial charge on the ring N atom, E(L UMO), and E(HOMO). The E(HOMO) correlation is qualitatively inconsiste nt as the HOMO is not the same orbital in all compounds. The E(LUMO) c orrelation [pEMR = 1.19(+/-0.21)E(LUMO) + 5.41(+/-1.05), n = 13, r = 0 .86, s = 0.274] suggests that the higher the E(LUMO) the more potent i s the analogue. This is inconsistent with simple charge transfer from the channel to the blocker and may refer to other processes which are important for the strength of the drug-K+ channel interaction such as the desolvation of the compounds.